Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Sale of 558 PTHS shares, $11.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Pelthos Therapeutics Inc. (PTHS) | Sale | 558 | $11.6K |
| Jul 7, 2026 | Pelthos Therapeutics Inc. (PTHS) | Sale | 534 | $13.9K |
| Jun 17, 2026 | Pelthos Therapeutics Inc. (PTHS) | Sale | 224 | $6.1K |
| May 18, 2026 | Pelthos Therapeutics Inc. (PTHS) | Tax Withholding | 144 | $3.9K |
| Apr 6, 2026 | Pelthos Therapeutics Inc. (PTHS) | Sale | 293 | $6.0K |
| Apr 1, 2026 | Pelthos Therapeutics Inc. (PTHS) | Grant/Award | 6,450 | n/a |
| Nov 26, 2025 | Pelthos Therapeutics Inc. (PTHS) | Sale | 5,999 | $168.0K |
| Jul 8, 2025 | Pelthos Therapeutics Inc. (PTHS) | Grant/Award | 19,108 | n/a |
| Jul 4, 2025 | Pelthos Therapeutics Inc. (PTHS) | Conversion | 40,000 | $400.0K |
| Nov 15, 2024 | Chromocell Therapeutics Corp (CHRO) | Grant/Award | 24,533 | n/a |